Literature DB >> 8913319

Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.

M W Davey1, R M Hargrave, R A Davey.   

Abstract

P-glycoprotein- and multidrug resistance-associated protein (MRP)-mediated multidrug resistance is associated with decreased drug accumulation. The P-glycoprotein-expressing CCRF-CEM/VLB100 subline and the MRP-expressing CCRF-CEM/E1000 subline are both 50-fold resistant to daunorubicin. However, accumulation of daunorubicin and rhodamine 123 was > 85% reduced in the P-glycoprotein-expressing subline compared to 40-50% in the MRP-expressing subline. Further, the CCRF-CEM/E1000 cells were 30-fold resistant to idarubicin, without reduced accumulation. Verapamil and SDZ PSC 833 restored daunorubicin and rhodamine 123 accumulation, while buthionine sulphoximine affected only the CCRF-CEM/ E1000 subline. We conclude that the verapamil associated change in rhodamine 123 accumulation provides a sensitive functional assay for both P-glycoprotein- and MRP-mediated MDR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913319     DOI: 10.1016/0145-2126(96)00023-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1.

Authors:  Ross A Davey; Mary W Davey; Karen V Cullen; Xanthe E Wells; Craig L Francis; Hua-Ming Williams; Qi Yang; Minoo J Moghaddam; Fred Widmer; Robert G Whittaker
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Carbamazepine is not a substrate for P-glycoprotein.

Authors:  A Owen; M Pirmohamed; J N Tettey; P Morgan; D Chadwick; B K Park
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

3.  A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells.

Authors:  Jamie F Lu; Deep Pokharel; Mary Bebawy
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

4.  Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.

Authors:  Sreeja Sudhakaran; Craig R Rayner; Jian Li; David C M Kong; Neil M Gude; Roger L Nation
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

5.  Intracellular 'boosting' of darunavir using known transport inhibitors in primary PBMC.

Authors:  Wai San Kwan; Omar Janneh; Ruben Hartkoorn; Becky Chandler; Saye Khoo; David Back; Andrew Owen
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

6.  Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter.

Authors:  Jean-Michel Michot; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir.

Authors:  O Janneh; R C Hartkoorn; E Jones; A Owen; S A Ward; R Davey; D J Back; S H Khoo
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

8.  P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.

Authors:  Gerard Minuesa; Cristina Arimany-Nardi; Itziar Erkizia; Samandhy Cedeño; José Moltó; Bonaventura Clotet; Marçal Pastor-Anglada; Javier Martinez-Picado
Journal:  J Antimicrob Chemother       Date:  2016-06-21       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.